<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
< Back to all Breaking News
BGNE
1/21/2020 07:01am
BeiGene says Phase 3 trial of tislelizumab meets primary endpoint

dynamic_feed Breaking News